Technical Analysis for FLXN - Flexion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 27.53 0.15% 0.04
FLXN closed up 0.15 percent on Tuesday, May 22, 2018, on 77 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical FLXN trend table...

Date Alert Name Type % Chg
May 22 Stochastic Sell Signal Bearish 0.00%
May 22 NR7 Range Contraction 0.00%
May 22 NR7-2 Range Contraction 0.00%
May 22 Upper Bollinger Band Walk Strength 0.00%
May 22 Inside Day Range Contraction 0.00%
May 22 Overbought Stochastic Strength 0.00%
May 22 Upper Bollinger Band Touch Strength 0.00%
May 21 NR7 Range Contraction 0.15%
May 21 Upper Bollinger Band Walk Strength 0.15%
May 21 Overbought Stochastic Strength 0.15%

Older signals for FLXN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Flexion Therapeutics, Inc. focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. Its lead product candidate includes FX006, an intra-articular, sustained-release triamcinolone acetonide, which has completed a Phase 2b dose-ranging clinical trial to treat moderate to severe osteoarthritis (OA) pain. The company is also developing FX007, a preclinical, small-molecule TrkA receptor antagonist to address post-operative pain; and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor, which has completed a Phase 2a clinical trial to treat end-stage OA patients. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
Is FLXN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.25
52 Week Low 16.51
Average Volume 680,506
200-Day Moving Average 24.4995
50-Day Moving Average 24.9856
20-Day Moving Average 26.0375
10-Day Moving Average 26.438
Average True Range 1.1246
ADX 20.06
+DI 25.54
-DI 13.47
Chandelier Exit (Long, 3 ATRs ) 24.6262
Chandelier Exit (Short, 3 ATRs ) 27.5238
Upper Bollinger Band 27.6824
Lower Bollinger Band 24.3926
Percent B (%b) 0.95
BandWidth 12.634854
MACD Line 0.6137
MACD Signal Line 0.4354
MACD Histogram 0.1783
Fundamentals Value
Market Cap 878.35 Million
Num Shares 31.9 Million
EPS -3.11
Price-to-Earnings (P/E) Ratio -8.85
Price-to-Sales 0.00
Price-to-Book 3.08
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.45
Resistance 3 (R3) 28.49 28.23 28.29
Resistance 2 (R2) 28.23 28.00 28.21 28.24
Resistance 1 (R1) 27.88 27.85 27.75 27.84 28.19
Pivot Point 27.62 27.62 27.56 27.60 27.62
Support 1 (S1) 27.27 27.39 27.14 27.23 26.87
Support 2 (S2) 27.01 27.24 26.99 26.82
Support 3 (S3) 26.66 27.01 26.77
Support 4 (S4) 26.62